Development of a sensitive and specific liquid chromatography/mass spectrometry method for the determination of tenofovir in human plasma

Rapid Communications in Mass Spectrometry

Volumn 21, Issue 13, 2007, Pages 2087-2094

  Bennetto Hood, Chantelle ^a   Long, Mary C ^a   Acosta, Edward P ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION; PLASMA (HUMAN); SOFTWARE TESTING;

ATLANTIS; CATION EXCHANGE CARTRIDGE; CHROMATOGRAPHIC SEPARATIONS; HUMAN PLASMAS; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-MASS SPECTROMETRIES; PLASMA SAMPLES; REVERSED PHASE; SOLID-PHASE EXTRACTION; TENOFOVIR;

QUALITY CONTROL;

EID: 34347215514     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3056     Document Type: Article

References (18)

1. Kearney BP, Flaherty JF, Shah Jaymin. Clin. Pharmacokinet. 2004; 43: 595.
2. Gilead Sciences Inc. Tenofovir disoproxil fumarate (Viread®) tablets: prescribing information. Foster City, CA, 2003.
3. Wainberg MA, Miller MD, Quan Y, Salomon H, Mulato AS, Lamy PD, Margot NA, Anton KE, Cherrington JM. Antiviral Ther 1999; 4: 87.
4. Srinivas RV, Fridland A. Antimicrob. Agents Chemother. 1998; 42: 1484.
5. Jullien V, Treluyer JM, Pons G, Rey E. J. Chromatogr. B 2003; 785: 377.
6. Sparidans RW, Crommentuyn RML, Schellens JHM, Beijnen JH. J. Chromatogr B 2003; 791: 227.
7. Lynch T, Eisenberg G, Kernan M. Nucleosides, Nucleotides Nucleic Acids 2001; 20: 1415.
8. Delahunty T, Bushman L, Hetcher CV. J. Chromatogr B 2006; 830: 6.
9. King T, Bushman L, Kiser J, Anderson PL, Ray M, Delahunty T, Hetcher CV. J. Chromatogr. B 2006; 843: 147.
10. Bezy V, Morin P, Couerbe P, Leleu G, Agrofoglio L. J. Chromatogr. B 2005; 821: 132.
11. US Department of Health and Human Services Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services: Rockville, MD, 2001. Available: http://www.fda. gov/cder/guidance/index.htm.
12. Sentenac S, Fernandez C, Thuillier A, Lechat P, Aymard G. J. Chromatogr. B 2003; 793: 317.
13. Parks DA, Jennings HC, Taylor CW, Acosta EP. Presented at 3rd IAS Conference on HIV Pathogenesis and Treatment, 2005.
14. Mallet CR, Lu A, Mazzeo JR. Rapid Commun Mass Spectrom 2004; 18: 49.
15. Holland DT, DiFrancesco R, Stone J, Hamzeh F, Connor JD, Morse GD. Antimicrob. Agents Chemother. 2004; 48: 824.
16. Lynch T, Eisenberg G, Kernan M. Nucleosides, Nucleotides Nucleic Acids 2001; 20: 1415.
17. Delahunty T, Bushman L, Fletcher CV. J. Chromatogr. B 2006; 830: 6.
18. King T, Bushman L, Kiser J, Anderson PL, Ray M, Delahunty T, Fletcher CV. J. Chromatogr. B 2006; in press.